NCT00421707 - Randomized Placebo Controlled Efficacy And Safety Study Investigating GW876008 In Patients With Irritable Bowel Syndrome | Biotech Hunter

Enrollment

133

Participants

Timeline

Start Date

October 14, 2006

Primary Completion Date

June 25, 2008

Study Completion Date

June 25, 2008

Conditions

Irritable Bowel Syndrome (IBS)

Interventions

DRUG

GW876008

OTHER

Placebo

Trial Locations (23)

24502

GSK Investigational Site, Lynchburg

27408

GSK Investigational Site, Greensboro

29621

GSK Investigational Site, Anderson

29651

GSK Investigational Site, Greer

30281

GSK Investigational Site, Stockbridge

33614

GSK Investigational Site, Tampa

37404

GSK Investigational Site, Chattanooga

38138

GSK Investigational Site, Germantown

40202

GSK Investigational Site, Louisville

63110

GSK Investigational Site, St Louis

71201

GSK Investigational Site, Monroe

72120

GSK Investigational Site, Sherwood

78209

GSK Investigational Site, San Antonio

78705

GSK Investigational Site, Austin

90095

GSK Investigational Site, Los Angeles

94520

GSK Investigational Site, Concord

02215

GSK Investigational Site, Boston

B2N 1L2

GSK Investigational Site, Truro

M3H 5S4

GSK Investigational Site, Toronto

M3J 1N2

GSK Investigational Site, Toronto

M3N 2V7

GSK Investigational Site, Toronto

M9W 4L6

GSK Investigational Site, Toronto

S7K 1J5

GSK Investigational Site, Saskatoon